Ketryx, the AI-native compliance platform for safety-critical product development, today announced record momentum entering 2026, driven by surging demand for validated AI in the medical device, digital health, diagnostics, and life sciences sectors. The company reported that four of the top five Fortune 500 MedTech companies now run on Ketryx, and its platform supports products reaching more than 100 million patients worldwide. This milestone underscores a broader industry shift from AI experimentation to enterprise-wide deployment, where safety and compliance are paramount.
According to the company's announcement, Ketryx has proven that safety-critical product development no longer has to be slow. The platform overlays existing tools to automate documentation, create traceability, and accelerate release cycles without disrupting workflows. Ketryx AI Agents, a key feature, reportedly cut manual work by 90 percent and close compliance gaps, enhancing both speed and quality across the entire product lifecycle. The company's success reflects the increasing need for validated AI systems in regulated industries, where traditional development processes often struggle to keep pace with innovation.
The news comes as regulators and industry bodies emphasize the importance of AI validation in healthcare. For medical device and life sciences companies, the ability to deploy AI while maintaining compliance with standards such as FDA regulations is critical. Ketryx's platform addresses this challenge by embedding compliance into the development process from the start, rather than treating it as an afterthought. The company's growing customer base among top MedTech firms indicates that validated AI is no longer a niche requirement but a competitive necessity.
As demand for validated AI surges, Ketryx's record momentum highlights a broader trend: the convergence of AI and regulatory compliance in safety-critical industries. The company's ability to serve over 100 million patients demonstrates the real-world impact of its platform, enabling faster delivery of safer products. With four of the top five Fortune 500 MedTech companies already on board, Ketryx is well-positioned to lead the market in AI-native compliance solutions. For more information, visit www.ketryx.com.
